Total for the last 12 months
number of access : ?
number of downloads : ?
ID 117577
Author
Hasegawa, Naomi National Center of Neurology and Psychiatry
Takaesu, Yoshikazu Kyorin University
Takeshima, Masahiro Akita University
Onitsuka, Toshiaki Kyushu University
Nakamura, Toshinori Shinshu University
Edagawa, Reon Tokushima University
Edo, Hiroaki Tokushima University
Miura, Kenichiro National Center of Neurology and Psychiatry
Matsumoto, Junya National Center of Neurology and Psychiatry
Yasui-Furukori, Norio Dokkyo Medical University
Kishimoto, Taishiro Keio University
Hori, Hikaru University of Occupational and Environmental Health
Tsuboi, Takashi Kyorin University
Yasuda, Yuka National Center of Neurology and Psychiatry|Medical Corporation Foster
Furihata, Ryuji Nihon University|Kyoto University
Muraoka, Hiroyuki Tokyo Women’s Medical University
Ochi, Shinichiro Ehime University
Nagasawa, Tatsuya Kanazawa Medical University
Kyou, Yoshitaka Kitasato University
Murata, Atsunobu National Center of Neurology and Psychiatry
Katsumoto, Eiichi Katsumoto Mental Clinic
Ohi, Kazutaka Gifu University
Hishimoto, Akitoyo Yokohama City University
Inada, Ken Tokyo Women’s Medical University
Watanabe, Koichiro Kyorin University
Hashimoto, Ryota National Center of Neurology and Psychiatry
Keywords
clinical practice guidelines
degree of understanding
depression
dissemination
education
implementation
schizophrenia
Content Type
Journal Article
Description
Background: To implement clinical practice guidelines (CPGs), it is necessary for psychiatrists to deepen their understanding of the CPGs. The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project is a nationwide dissemination and implementation study of two sets of CPGs for schizophrenia and major depressive disorder (MDD).
Methods: A total of 413 psychiatrists (n = 212 in 2016; n = 201 in 2017) learned the two CPGs in the education program of the EGUIDE project, and clinical knowledge of these CPGs was evaluated at baseline and after the programs. To improve the correct answer rate for clinical knowledge after the programs, we revised the lecture materials associated with items that had a low correct answer rate in 2016 and used the revised lecture materials with the CPGs in 2017. The rates of correct answers after the programs between the 2016 and 2017 groups were compared.
Results: The correct answer rate of one item on the schizophrenia CPG and one item on the MDD CPG tended to be improved (S-D5 and D-C6) and that of one on the MDD CPG was significantly improved (D-D3, P = 0.0008) in the 2017 group compared to those in the 2016 group.
Conclusions: We reported improvements in clinical knowledge of CPGs after the EGUIDE program in the 2017 group following revision of the lecture materials based on results from the 2016 group. These attempts to improve the degree of understanding of CPGs may facilitate the successful dissemination and implementation of psychiatric guidelines in everyday practice.
Journal Title
Neuropsychopharmacology Reports
ISSN
2574173X
Publisher
The Japanese Society of Neuropsychopharmacology|John Wiley & Sons
Volume
41
Issue
2
Start Page
199
End Page
206
Published Date
2021-03-11
Rights
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences
University Hospital